Discovery of more aspirin benefits being slowed by the drug's success

07/9/2004 | Guardian (London), The

The discovery of aspirin's many benefits, from treating cancer to dementia, is the result of decades of clinical studies and hard scientific investigation, but future discoveries are in doubt because of obstacles to further research. One problem is that researchers are reluctant to give a placebo in an aspirin trial for fear a patient might succumb to a disease, while fewer people are willing to take part in trials if they might only get a placebo.

View Full Article in:

Guardian (London), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA